Explorer les evidences

0,7 %The prevalence of a new HIV diagnosis was 0.7% (2 of 301) among patients with cancer in a cohort attending a tertiary hospital in Nairobi, Kenya, between February 2021 and September 2021.

KenyaVIH/sidaobservé February 2021 to September 2021publié 2023JCO global oncologyPubMeddocument de 8 observations

14 %The upper boundary of HIV seroprevalence was 14% among the 171 cancer cases meeting at least one strength-of-evidence criterion for HIV infection/AIDS.

Kenyacancer (non précisé) · VIH/sidaobservé August 1 to October 31, 2011publié 2014PloS oneeurope_pmcdocument de 4 observations

44 628 individualsThe number of active children living with HIV on treatment at the end of US Government fiscal year 2019 was 44,628.

KenyaVIH/sidaobservé FY 2019publié 2025The Pediatric infectious disease journalPubMeddocument de 10 observations

2 foldHIV-1 subtype D infection is associated with a >2-fold higher risk of death than subtype A infection.

KenyaVIH/sidapublié 2007The Journal of infectious diseaseseurope_pmcdocument de 2 observations

0 casesNo women acquired HIV during the study period.

KenyaVIH/sidapublié 2024Journal of the International AIDS SocietyPubMeddocument de 8 observations

243 recordsOf the 1,154 medical records abstracted, 243 (21%) were from adolescent girls and young women seeking HIV prevention services.

KenyaVIH/sidapublié 2023Frontiers in public healthPubMeddocument de 9 observations

56,9 pg/mlThe median (IQR) levels of TGF-β were 56.9 (50.0–67.8) pg/ml in pLLV participants and 27.7 (19.5–34.7) pg/ml in virally suppressed participants on first-line cART.

KenyaVIH/sidapublié 2025The Pan African medical journalPubMeddocument de 11 observations

76 %At enrolment, 536 (76%) of 704 participants had documented virological suppression.

KenyaVIH/sidapublié 2022The Lancet. Child & adolescent healthPubMeddocument de 12 observations

50 %In the SEARCH Study in rural Kenya and Uganda (2013–2017), 50% of HIV-positive persons had viral suppression at baseline according to unadjusted estimates.

KenyaVIH/sidaobservé 2013-2017publié 2020Epidemiology (Cambridge, Mass.)PubMeddocument de 8 observations

Nationally, improvements in under-five mortality after 2006 were associated with a decline in the prevalence of HIV and malaria, increase in access to better sanitation, fever treatment-seeking rates and maternal autonomy.

Kenyapaludisme · VIH/sidaobservé after 2006publié 2021BMC medicineeurope_pmcdocument de 7 observationsDOI 10.1186/s12916-021-01974-x

5,9 percentage_pointsAmong people with HIV aged ≥40 years (n = 3036), the prevalence of blood pressure ≥140/90 mmHg decreased by 5.9 percentage points (95% CI 3.0%, 8.8%).

Kenyahypertension artérielle · VIH/sidapublié 2025Journal of the International AIDS SocietyPubMeddocument de 11 observations

81,5 %Among unsuppressed participants, 81.5% had evidence of any major HIV drug-resistance mutation in Kenya from 2018 to 2020.

KenyaVIH/sidaobservé 2018-2020publié 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 5 observations

2,77 mL/m²People living with HIV had 2.77 mL/m² larger left atrial volume compared with the HIV-negative group after adjusting for risk factors associated with diastolic dysfunction.

KenyaVIH/sidapublié 2022Open heartPubMeddocument de 9 observations

63 samplesSixty-three out of 80 HIV-positive individuals on antiretroviral therapy in Teso, Western Kenya had successful sequencing of the partial pol gene.

KenyaVIH/sidaobservé 2019publié 2021The Pan African medical journalPubMeddocument de 7 observations

51 %Among 607 survey responders (86% of 704 seroconverters), 51% of women reported a spouse as the suspected infection source.

KenyaVIH/sidapublié 2021PloS onePubMeddocument de 16 observations

3,2 %Among 5200 under-5 deaths with an assigned cause in the CHAMPS network, 164 (3.2%) had HIV in the causal chain.

KenyaVIH/sidaobservé Dec 3, 2016 to Dec 31, 2024publié 2026The lancet. HIVPubMeddocument de 23 observations

14 %Among people with a PrEP indication and an HIV test in the past 3 months, the median proportion of people on PrEP was 14% with no DCP.

KenyaVIH/sidapublié 2025The lancet. HIVPubMeddocument de 11 observations

36,2 %The mean guideline adherence score for preexposure prophylaxis (PrEP) care was 36.2% at control sites.

KenyaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 9 observations

0 casesNo instances of HIV, syphilis, or hepatitis C were identified in the tested blood samples.

Kenyahépatite C · syphilis · VIH/sidapublié 2026Global health, epidemiology and genomicsPubMeddocument de 3 observations

8 daysTime to enhanced adherence counseling following detection of high viral load was reduced by a median of 8 days, from 49 days to 41 days before versus after implementation of the standardized enhanced adherence counseling package.

KenyaVIH/sidapublié 2022MedicinePubMeddocument de 12 observations

31 %Mean predicted risk probability among pregnant and postpartum women with HIV with a new HIV diagnosis was 31% in the low-risk quintile.

KenyaVIH/sidapublié 2025AIDS and behaviorPubMeddocument de 13 observations

47,5 daysTime to completion of at least 3 enhanced adherence counseling sessions was 47.5 days after implementation of the standardized enhanced adherence counseling package.

KenyaVIH/sidapublié 2022MedicinePubMeddocument de 12 observations

91,4 %Among children eligible for antiretroviral therapy (ART) after HIV diagnosis via family-centered index testing in Kenya, 91.4% initiated ART.

KenyaVIH/sidaobservé 2015–2016publié 2020International journal of STD & AIDSPubMeddocument de 7 observations

1,29 aORDelayed HIV PCR testing for early infant diagnosis was associated with an adjusted odds ratio of 1.29 for yielding a positive result.

KenyaVIH/sidapublié 2021BMC public healthPubMeddocument de 11 observations

5,8 per_100_person-yearsThe incidence of first incident pregnancies among female sex workers living with HIV in Mombasa, Kenya was 5.8 per 100 person-years between October 2012 and April 2017.

KenyaVIH/sidaobservé October 2012-April 2017publié 2020Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 10 observations